All
Chemo-Related Hearing Loss Is Common in Survivors of Testicular Cancer, Other Cancer Types
March 6th 2023With 74% of testicular cancer survivors reporting hearing loss in a recent study, one expert advised patients to advocate for themselves and their hearing before, during and after cancer treatment with cisplatin-based chemotherapy.
FDA Expands Verzenio Indication to Forego Ki-67 Score in High-Risk, Early Breast Cancer
March 6th 2023Removing the Ki-67 score to determine eligibility for Verzenio treatment in patients with HR-positive, HER2-negative, node positive, early breast cancer allows for more patients to receive this treatment.